Why We Downgraded MDS

MDS INC. $19 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; SI Rating: Average) is still having problems with its drug-testing lab in Montreal, which is currently under review by the U.S. Food and Drug Administration.

The company estimates that this review cut its earnings by… Read More